Fundz

Cyclacel Pharmaceuticals reported raising $2.06 Million in an initial SEC Form D filing, from an offering of $2.06 Million

PUBLIC · BGMSNov 26, 2024

Amount Raised

$2.06 Million

$2.06 Million sold, per SEC Form D (first sale Nov 14, 2024)

Round Type

Seed

Berkeley HeightsBiotechnologyTherapeuticsPharmaceuticalBiopharma

Who else raised in Therapeutics and Pharmaceutical around the same time

Companies in the same sectors as Bio Green Med Solution, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Lipella Pharmaceuticals raised $2.6M (Seed) on December 23, 2024.
  • Ensho Therapeutics raised $5M on October 24, 2024.
  • Seaport Therapeutics raised $225M (Series B) on October 21, 2024.
  • SystImmune raised $7.9M on October 18, 2024.
  • Seaport Therapeutics raised $226M on October 18, 2024.
  • OnKure Therapeutics raised $65M on October 4, 2024.

Who to call at Bio Green Med Solution, Inc., and when

A new round usually means Bio Green Med Solution, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Bio Green Med Solution, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Bio Green Med Solution, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Bio Green Med Solution, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Bio Green Med Solution, Inc.

Location

200 CONNELL DRIVE, SUITE 1500

Berkeley Heights, New Jersey, United States

About

Cyclacel Pharmaceuticals, Inc. is a biopharmaceutical company developing innovative cancer medicines based on cell cycle, transcriptional regulation, epigenetics, and mitosis biology. The Company's strategy is to build a diversified biopharmaceutical business based on a pipeline of novel drug candidates addressing oncology and hematology indications.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Bio Green Med Solution, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Predictive Intelligence
Strategic

ML-powered predictions for Bio Green Med Solution, Inc.'s next move

See what Strategic adds

Bio Green Med Solution, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.